A proficient ddr has been shown to be a primary cause for cellular resistance to the very many dna damaging drugs, and ir, that are widely used as standardofcare across multiple cancer types. General organization of the dna damage response pathway the dna damage response pathway is a signal transduction pathway consisting of sensors, transducers and effectors fig. Interference with dna repair has emerged as an important approach in combination therapy against. Aberrant dna methylation is an epigenetic hallmark of melanoma, known to play important roles in melanoma formation and progression. Pearl is head of the school of life sciences at the university of sussex, brighton, uk, and professor of structural biology in the genome damage and stability centre. To help identify new therapeutic opportunities within the ddr.
Dna damage response ddr defects imply genomic instability and favor tumor progression but make the cells vulnerable to the pharmacological inhibition of the dna repairing enzymes. Crisprcas9based dna damage response screens reveal gene. Trinucleotide repeat disorders are severe, usually lifeshortening, neurological disorders caused by nucleotide expansions, and most have no diseasemodifying treatments. Cancer is a death cause in economically developed countries that results growing also in developing countries. Deficiencies in these responses, particularly in repair of different damaged dna are of tremendous importance in the etiology of human cancers and at the same time offer great opportunities for designing targeted therapeutic strategies. Although these processes drive genomic instability and ultimately the disease process, they also provide therapeutic opportunities. Cin is induced by chromosome missegregation in mitosis and leads to karyotypic diversity within the cancer cell population, thereby adding to intratumor heterogeneity. Translational and basic science opportunities in palliative. At the heart of the ddr are the related signaling kinases atm, atr, and dnapk, which regulate dna repair and associated events such as cell cycle checkpoints, chromatin remodeling, transcription, and. Request pdf therapeutic opportunities within the dna damage response the dna damage response ddr is essential for maintaining the genomic integrity of. Traip regulates histone h2b monoubiquitination in dna damage. Translational and basic science opportunities in palliative care and radiation oncology radiation therapy is commonly used in the metastatic setting to palliate pain, neurological deficits, bleeding and other complications of metastatic disease, allowing patients to. Collectively, these mechanisms are known as the dna damage response ddr.
Use of poly adpribose polymerase parp inhibitors in cancer. Inhibiting the dna damage response as a therapeutic. Defects of dna damage response are considered as a hallmark of human cancer. Request pdf therapeutic opportunities within the dna damage response the dna damage response ddr is essential for maintaining the genomic integrity of the cell, and its disruption is one of.
Recent studies show that cdk5 participates in a series of biological and pathological processes in nonneuronal cells, and is generally. Although recent data indicate that h2b monoubiquitination is strongly connected with tumor progression and regulation, the implications of this modification in lung adenocarcinoma are relatively unknown. As an atypical member of cyclin dependent kinase family, cyclin dependent kinase 5 cdk5 is considered as a neuronspecific kinase in the past decade due to the abundant existence of its activator p35 in postmitotic neurons. These targets include the protein kinases involved in cell cycle dna checkpoint for dna damage andor replicative stress eg chek1, wee1, and individual. Kinase targeting combined with dnadamaging cancer therapy catalyzes mitotic. The balance between dna damage and repair determines the final therapeutic consequences. The dna damage response ddr network includes multiple cellular pathways that sense, signal and repair dna lesions, which are critically important for cell survival and genome maintenance. Here we performed a genomewide shrna screen and found that loss of the nucleosome remodeling factor chd4 confers cisplatin resistance. This chapter outlines the discovery of the parp family and the rationale for the development of parp inhibitors as a novel class of anticancer agents, with a brief evaluation of the preclinical evidence for chemopotentiation, radiopotentiation, and also single agent activity in homologous recombination. Sarscov2 transmission sarscov2 is highly infectious. Dna damaging agents have a central role in nonsurgical cancer treatment. Therapeutic opportunities within the dna damage response nature.
Targeting oxidatively induced dna damage response in. Although we refer to this as a pathway, it is more accurately described as a networkof interacting pathways that together execute the response. Longer repeat expansions are associated with genetic anticipation ie, earlier. Alterations in dna repair promote tumor development, but the impact on tumor progression is poorly understood. The outcome is quantified as log 10 fold change of cell number after 3 days of the drug. Modeling chemotherapyinduced stress to identify rational. Chromosomal instability cin is the result of ongoing changes in the number aneuploidy and structure of chromosomes. There are likely many additional opportunities to exploit the dna damage response for the benefit of cancer patients, given that genome instability is a hallmark of cancer and there is intense. Genomic instability is a typical cancer hallmark due to dna damage by genetic mutations, reactive oxygen and. In addition, many therapies are scarcely selective for cancer cells and damage healthy cells thus compromising the therapeutic effect 5.
Resistance to therapy in brca2 mutant cells due to loss of. Hypoxia and cancer biological implications and therapeutic. Use of poly adpribose polymerase parp inhibitors in. May 17, 20 the dna damage response ddr, consisting of an orchestrated network of proteins effecting repair and signalling to cell cycle arrest, to allow time to repair, is essential for cell viability and to prevent dna damage being passed on to daughter cells. Histone h2b monoubiquitination has been shown to play critical roles in diverse cellular processes including dna damage response. Targeting cellular proteins like parps, which cooperate and complement molecular defects of the ddr process, induces a specific lethality in ddr defective cancer cells and. Jul 24, 2018 the inhibition of eight molecular targets within the dna damage response pathway atm, atr, dna pk, chk1, chk2, p53, p21, and chk12 was simulated. Jci cellular senescence and the senescent secretory. While parp inhibitors have led the way, and are increasingly being recognized as a targeted therapeutic approach for patients with brca mutations and. Dna doublestrand breaks dsbs a critical feature of the eukaryotic cell is its ability to maintain genome stability across generations, attributed, in part, to the sophisticated and precisely.
Over the past decade a complex role for dna damage response ddr in tumorigenesis has emerged. Table 1 pathways involved in the dna damage response and the number of genes associated with each pathway. A better understanding of the cellular response to dna damage will not only inform our knowledge of cancer development but also help to refine the classification as well as the treatment of the disease. The dna damage response ddr is a crucial signalingtransduction. The dna damage response ddr is essential for maintaining the genomic integrity of the cell, and its disruption is one of the hallmarks of cancer.
The ddr detects aberrant dna and chromosomal structures and elicits a multifaceted response network to coordinate multiple cellular processes, including regulation of the cell cycle, dna repair, replication and, under certain circumstances, the triggering of programmed cell death. In mammalian cells, the dna damage response ddr prevents the replication and propagation of dna errors to the next generation, thus maintaining genomic stability. Targeting the dna damage response for anticancer therapy. Cellular senescence refers to the essentially irreversible growth arrest that occurs when cells experience potentially oncogenic insults 3338. Improved outcome through targeted interventions faces the scarce selectivity of the therapies and the development of resistance to them that compromise the therapeutic effects. Role of nbs1 in dna damage response and its relationship. Signatureguided approaches for targeting dna damage response. The ongoing molecular characterization of the dna damage response ddr and pathway crosstalk is invaluable in helping scientists learn how to modulate dna repair. Longer repeat expansions are associated with genetic anticipation ie, earlier disease onset in. Traip regulates histone h2b monoubiquitination in dna.
The dna damage response ddr, consisting of an orchestrated network of proteins effecting repair and signalling to cell cycle arrest, to allow time to repair, is essential for cell viability and to prevent dna damage being passed on to daughter cells. Dna damage response pathways and cancer clinical gate. Jul, 2017 normal longterm hscs are in quiescent state within the bonemarrow niche, but in response to stressinducing stimuli such as viral infections, cytopenias, cytokines e. Interference with dna repair has emerged as an important approach in. These lesions can block genome replication and transcription, and if they are not repaired or are repaired incorrectly, they lead to mutations or widerscale genome aberrations that threaten cell or organism viability. Despite a longstanding understanding that many endogenous and exogenous agents can damage dna, knowledge of how dna repairs itself was largely an academic pursuit until the last two decades. Even within a specific category of dna damage, the machinery utilized for repair varies due to the chemistry of the damage, the damage context, differential expression or posttranslational modification of repair factors, the chromatin state and the cell cycle. Evaluating the moleculebased prediction of clinical drug. Therapeutic opportunities within the dna damage response laurence h. Therapeutic opportunities within the dna damage response. An elevated dna repair capacity in tumor cells leads to drug or radiation resistance and severely limits the efficacy of these agents. As research advances, we continue to expand our knowledge and understanding of novel targets in dna damage response as potential therapeutic options in oncology. Reviews the dna damage response in human biology and disease stephen p.
Cancerassociated defects in the dna damage response. Senescencecausing inducers include repeated cell division and strong mitogenic signals, telomere shortening, dna damage and mutations, protein aggregation, and increased ros 46, 56 60. More recently, protein components of the ddr systems have been identified. The cell cycle comprises the sequence of coordinated events that take place in a cell, known as cell cycle phases, that enable the cell to faithfully duplicate its. Cellular senescence and the senescent secretory phenotype. Reviews the dnadamage response in human biology and disease stephen p. Regardless of the overall prooncogenic function of cin, its onset is typically detrimental for cell fitness. A hormonedna repair circuit governs the response to.
Targeting cellular proteins like parps, which cooperate and complement molecular defects of the ddr process, induces a specific lethality in ddr defective cancer cells and represents an anticancer strategy. In cancer, the critical balance between the loss of genomic stability in malignant cells and the ddr provides exciting therapeutic opportunities. Targeted therapy based on inhibiting the dna damage response. Dna repair in the trinucleotide repeat disorders the. The dna damage response ddr network is a system of cellular pathways that monitor and repair dna damage in an effort to maintain genomic integrity throughout the cell cycle. Moleculebased prediction of drug response is one major task of precision oncology. Aside from dnadamaging chemotherapeutic agents, nfkb inhibition in breast cancer cells can.
The complexity of dna damage response ddr molecular networks their role in preventing the tumorigenic process therapeutic opportunities opportunities and challenges for combination therapy summary this slide is the intellectual property of the authorpresenter. The role and clinical significance of dna damage response and. Elucidating the complexity of ddr network will contribute meaningfully and decisively to our understanding of cancer biology and cancer treatment. Targeting the dna damage response in cancer sciencedirect. Regardless of the overall prooncogenic function of cin, its onset is. Hypoxia inducible factor 1 hif1 is a master regulator of the transcriptional response to oxygen deprivation. Dna damage elicits various response pathways, which aim to repair the damage or eliminate cells if the damage is beyond repair. Genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of dna damage, tumourspecific dna repair defects, and a failure to stop or. Findings show that androgen receptor ar activity is induced by dna damage and promotes expression and activation of a. The effect of chemotherapies is simulated as monotherapy or in combination bars and shown on the x axis.
Restoration of cisplatin resistance is independent of hr but correlates with restored cell cycle progression, reduced chromosomal aberrations, and enhanced dna damage tolerance. Cdk5 links with dna damage response and cancer molecular. Targeting oxidatively induced dna damage response in cancer. Parp and novel dna damage response ddr inhibitors are showing great potential in broader tumor indications as they advance through the clinic. These insults activate the p53 and p16 ink4a tumor suppressor pathways and potentially other pathways that initiate a senescence response.
U nexpectedly, clinical observations suggest that steroid hormones might modulate the response to dna damage in hormoneresponsive cancers. The dna damage response ddr is a collective term for the plethora of different intra and intercellular signaling events and enzyme activities that result from the induction and detection of dna damage. Emerging cancer therapeutic opportunities target dna. These include events that lead to cellcycle arrest, regulation of dna replication, and the repair or bypass of dna damage. Molecular targets and clinical applications, second edition provides a comprehensive and timely reference that focuses on the translational and clinical use of dna repair as a target area for the development of diagnostic biomarkers and the enhancement of cancer treatment experts on dna repair proteins from all areas of cancer. Cancer associated defects in the dna damage response. Mrc genome damage and stability centre, school of life sciences, university of sussex, falmer, brighton, bn1 9rq 2. One basic process that may contribute to agerelated dysfunction and chronic sterile inflammation is cellular senescence figure figure2.
The inhibition of eight molecular targets within the dna damage response pathway atm, atr, dnapk, chk1, chk2, p53, p21, and chk12 was simulated. An elevated dnarepair capacity in tumor cells leads to drug or radiation resistance and severely limits the efficacy of these agents. Jan 18, 2012 genomic instability is one of the most pervasive characteristics of tumour cells and is probably the combined effect of dna damage, tumourspecific dna repair defects, and a failure to stop or. Targeted therapy based on inhibiting the dna damage response ddr in cancers offers the potential for a greater therapeutic window by tailoring treatment to patients with tumors lacking specific ddr functions. Emerging cancer therapeutic opportunities target dnarepair. There is now strong evidence that cellular senescence is. Dna repair in the trinucleotide repeat disorders the lancet. The recent approval of olaparib lynparza, the poly adpribose polymerase parp. Here, discovery of a biochemical circuit linking hormone signaling to dna repair and therapeutic resistance is reported. This industryfocused summit will equip you with the tools to optimize parp inhibitors for expanded indications. Hif triggers the expression of genes whose products induce angiogenesis, decrease oxygen consumption, switch metabolism to glycolysis, maintain a stem cell phenotype and select for more invasive and metastatic cells. Role of nbs1 in dna damage response and its relationship with cancer development nijmegen breakage syndrome nbs is a recessive genetic disorder characterized by an elevated sensitivity to ionizing radiation, chromosome instability, and a high frequency of malignancies phenotypes similar to those of ataxiatelangiectasia at. Dna damage checkpoints initially were defined as regulatory pathways that control the ability of cells to arrest the cell cycle in response to dna damage, allowing time for repair. Inherited diseases caused by unstable repeated dna sequences are rare, but together represent a substantial cause of morbidity.
Genomic instability is a typical cancer hallmark due to dna damage by. Therapeutic opportunities within the dna damage response core. Inhibiting the dna damage response as a therapeutic manoeuvre. Dnadamaging agents have a central role in nonsurgical cancer treatment. The dna damage response pathway in normal hematopoiesis and. In general terms, the ddr can be divided into a series of distinct, but functionally interwoven, pathways, which are defined largely by the type of dna lesion they process fig. Excess iron is tightly associated with tumorigenesis in multiple human cancer types through a variety of mechanisms including catalyzing the formation of mutagenic hydroxyl radicals, regulating dna replication, repair and cell cycle progression, affecting signal transduction in cancer cells, and acting as an essential nutrient for proliferating tumor cells. Signatureguided approaches for targeting dna damage. The role and clinical significance of dna damage response. This complexity is particularly evident for dna alkylation damage. Classically, defects in the ddr have been exploited therapeutically in the treatment of cancer with radiation therapies or genotoxic chemotherapies.
Polyadpribosepolymerase 1 parp is a nuclear enzyme involved in dna repair. The dna damage response ddr is a signaling cascade of proteins that interact upstream with damaged dna and downstream with regulators of cell cycle progression and cell survival. The dna damage response pathway in normal hematopoiesis. The dnadamage response in human biology and disease. In addition, these somatic defects provide opportunities to exploit a reliance on remaining repair pathways for survival, a process which has been termed synthetic. The deoxyribonucleic acid dna damage response ddr pathway is a surveillance network, whereby lesions are eliminated from dna to ensure genomic integrity. Recently, largescale cancer genomic studies, such as the cancer genome atlas tcga, provide the opportunity to evaluate the predictive utility of molecular data for clinical drug responses in multiple cancer types. However, recent work has demonstrated that the ddr network extends far beyond the atrchk1 and atmchk2 axes. Dna damage response inhibition is an anticancer platform which could.
173 646 735 435 521 441 731 978 900 38 633 1104 102 921 1073 630 1288 718 1262 1335 115 21 68 761 801 966 605 1454 1117 679 508 1001 672 700 293 994 10 756 682 596